AGT and diabetic kidney disease: Recombinant human ACE2 prevented Ang II induced kidney disease and tubulointerstitial fibrosis [16] and slowed the progression of diabetic nephropathy through a reduction in renal Ang II and increased Ang 1–7 levels [17].